Ovid Therapeutics Inc
Biotechnology
Healthcare
OVID
71.11 M shares
NASDAQ US
traded
03 Sep 2025
listed
no
open
1.21
52 week high
1.33
high
1.34
52 week low
0.00
market cap
91.73 M
div yield
0
net incoming
-4.68 M
54.24 %
net profit margin
-74.68 %
7798.00 %
operating incoming
-5.07 M
59.58 %
net change in cash
7.28 M
240.93 %
cash on hand
28.42 M
34.44 %
cost of revenue
99.00 K
-65.14 %
top